March Biosciences

About:

March Biosciences is a clinical-stage cell therapy company that develops CAR-T cell strategies to address hematological cancers.

Website: https://march.bio

Top Investors: Mission BioCapital, Alexandria Venture Investments, KdT Ventures, Portal Innovations, TMC Venture Fund

Description:

March Biosciences is a clinical-stage cell therapy company that focuses on developing CAR-T cell strategies to address hematological cancers. The company's lead asset, MB-105, is a CD5-targeted CAR-T cell therapy currently in Phase 1 trials in patients with refractory T-cell lymphoma and leukemia.